Inhibitors of Rho kinases (ROCK) induce multiple mitotic defects and synthetic lethality in BRCA2-deficient cells.
Martino J, Siri SO, Calzetta NL, Paviolo NS, Garro C, Pansa MF, Carbajosa S, Brown AC, Bocco JL, Gloger I, Drewes G, Madauss KP, Soria G, Gottifredi V.
Martino J, et al. Among authors: calzetta nl.
Elife. 2023 Apr 19;12:e80254. doi: 10.7554/eLife.80254.
Elife. 2023.
PMID: 37073955
Free PMC article.